Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dow P Hurst

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Molecular Pharmacology|March 27, 2007
Mutation studies of Ser7.39 and Ser2.60 in the human CB1 cannabinoid receptor: evidence for a serine-induced bend in CB1 transmembrane helix 7Ankur Kapur, Dow P Hurst, Daniel Fleischer, et al.
Journal of Medicinal Chemistry|September 11, 2020
Therapeutic Exploitation of GPR18: Beyond the Cannabinoids?Paula Morales, Ana Lago-Fernandez, Dow P Hurst, et al.
Biotechnology Letters|November 20, 2016
A dual substrate kinetic model for cytochrome P450<sub>BM3</sub>-F87G catalysis: simultaneous binding of long chain aldehydes and 4-fluorophenolChelsea Ledford, Monica McMahon, Ashley Whitesell, et al.
The Journal of Biological Chemistry|March 12, 2010
A lipid pathway for ligand binding is necessary for a cannabinoid G protein-coupled receptorDow P Hurst, Alan Grossfield, Diane L Lynch, et al.
Molecular Pharmacology|November 21, 2014
(4-(Bis(4-fluorophenyl)methyl)piperazin-1-yl)(cyclohexyl)methanone hydrochloride (LDK1229): a new cannabinoid CB1 receptor inverse agonist from the class of benzhydryl piperazine analogsMariam M Mahmoud, Teresa Olszewska, Hui Liu, et al.
Journal of Medicinal Chemistry|November 14, 2003
An aromatic microdomain at the cannabinoid CB(1) receptor constitutes an agonist/inverse agonist binding regionSean D McAllister, Gulrukh Rizvi, Sharon Anavi-Goffer, et al.
BMC Cell Biology|March 21, 2012
Palmitoylation and membrane cholesterol stabilize μ-opioid receptor homodimerization and G protein couplingHui Zheng, Elizabeth A Pearsall, Dow P Hurst, et al.
Proteins|September 4, 2013
Global fold of human cannabinoid type 2 receptor probed by solid-state 13C-, 15N-MAS NMR and molecular dynamics simulationsTomohiro Kimura, Krishna Vukoti, Diane L Lynch, et al.
Bioorganic & Medicinal Chemistry|January 23, 2003
3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptorJohn W Huffman, Ross Mabon, Ming Jung Wu, et al.
The Journal of Biological Chemistry|December 19, 2013
Crucial positively charged residues for ligand activation of the GPR35 receptorPingwei Zhao, Tom R Lane, Helen G L Gao, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Molecular Pharmacology|March 27, 2007
Mutation studies of Ser7.39 and Ser2.60 in the human CB1 cannabinoid receptor: evidence for a serine-induced bend in CB1 transmembrane helix 7Ankur Kapur, Dow P Hurst, Daniel Fleischer, et al.
Journal of Medicinal Chemistry|September 11, 2020
Therapeutic Exploitation of GPR18: Beyond the Cannabinoids?Paula Morales, Ana Lago-Fernandez, Dow P Hurst, et al.
Biotechnology Letters|November 20, 2016
A dual substrate kinetic model for cytochrome P450<sub>BM3</sub>-F87G catalysis: simultaneous binding of long chain aldehydes and 4-fluorophenolChelsea Ledford, Monica McMahon, Ashley Whitesell, et al.
The Journal of Biological Chemistry|March 12, 2010
A lipid pathway for ligand binding is necessary for a cannabinoid G protein-coupled receptorDow P Hurst, Alan Grossfield, Diane L Lynch, et al.
Molecular Pharmacology|November 21, 2014
(4-(Bis(4-fluorophenyl)methyl)piperazin-1-yl)(cyclohexyl)methanone hydrochloride (LDK1229): a new cannabinoid CB1 receptor inverse agonist from the class of benzhydryl piperazine analogsMariam M Mahmoud, Teresa Olszewska, Hui Liu, et al.
Journal of Medicinal Chemistry|November 14, 2003
An aromatic microdomain at the cannabinoid CB(1) receptor constitutes an agonist/inverse agonist binding regionSean D McAllister, Gulrukh Rizvi, Sharon Anavi-Goffer, et al.
BMC Cell Biology|March 21, 2012
Palmitoylation and membrane cholesterol stabilize μ-opioid receptor homodimerization and G protein couplingHui Zheng, Elizabeth A Pearsall, Dow P Hurst, et al.
Proteins|September 4, 2013
Global fold of human cannabinoid type 2 receptor probed by solid-state 13C-, 15N-MAS NMR and molecular dynamics simulationsTomohiro Kimura, Krishna Vukoti, Diane L Lynch, et al.
Bioorganic & Medicinal Chemistry|January 23, 2003
3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptorJohn W Huffman, Ross Mabon, Ming Jung Wu, et al.
The Journal of Biological Chemistry|December 19, 2013
Crucial positively charged residues for ligand activation of the GPR35 receptorPingwei Zhao, Tom R Lane, Helen G L Gao, et al.
Pageof 6